Comparison of cervical cancer screening by self-sampling papillomavirus test versus pap-smear in underprivileged women in France.
Document Type
Journal Article
Author
Reques, Laura;
Rolland, Camille;
Lallemand, Anne;
Lahmidi, Najat;
Aranda-Fernández, Ezequiel;
Lazzarino, Antonio;
Bottero, Julie;
Hamers, Françoise;
Bergeron, Christine;
Haguenoer, Ken;
Launoy, Guy;
Luhmann, Niklas
Source
BMC Women's Health. 5/26/2021, Vol. 21 Issue 1, p1-14. 14p.
Subject
*CERVICAL cancer
*EARLY detection of cancer
*PAPILLOMAVIRUSES
*PAP test
*PAPILLOMAVIRUS disease diagnosis
*RESEARCH
*RESEARCH methodology
*MEDICAL screening
*MEDICAL cooperation
*EVALUATION research
*COMPARATIVE studies
CERVIX uteri tumors
Abstract
Background: The purpose of this study was to compare cervical cancer screening by pap smear (PS) versus preliminary HPV testing based on self-collected samples (SC-HPV).Methods: Interventional study among underprivileged women from 25 to 65 years old in four French cities. The control group (CG) was referred for a PS. The experimental group (EG) conducted a SC-HPV test followed by a PS in case of positivity. Differences on screening completion and cytological abnormalities were analysed by logistic and Cox regression.Results: 383 women were assigned to the EG and 304 to the CG. The screening completion proportion was 39.5% in the CG compared to 71.3% in the EG (HR = 2.48 (CI 95% [1.99-3.08]; p < 0.001). The proportion of cytological abnormalities was 2.0% in the CG and 2.3% in the EG (OR = 1.20 (CI 95% [0.42-3.40]; p = 0.7). The proportion of participants lost to follow-up was 60.5% in the CG and 63.2% in the EG HPV positive (p = 0.18).Conclusion: Providing an SC-HPV-test increased the participation of underprivileged women in CCS. Nevertheless, the significant number of lost to follow-up in both groups can undermine the initial benefits of the strategy for HPV positive women. Registration: Clinicaltrials.gov: NCT03118258. [ABSTRACT FROM AUTHOR]